Dihydroergotamine Mesylate Injection USP (DHE®)
| Generic Name | Dihydroergotamine Mesylate Injection USP |
|---|---|
| Brand Reference | DHE® |
| DIN | 00027243 |
| GTIN | 834324000091 |
| Strength | 1 mg / mL |
| Format | Ampoule |
| Pack Size | 5 |
| Therapeutic Class | Migraine Therapy |
| Product Monograph | Click Here |
Item Codes
| SteriMax: | ST-00900 |
|---|---|
| McKesson: | 181438 |
| K&F: | 29971 |
| McMahon: | 10064739 |
| Lawton's: | 930578 |
| Familiprix: | 662510 |
| Jean Coutu: | 750878 |
| SDM: | 834324000091 |
| Unipharm: | 00194159 |
| VDMA: | 014931 |
Latex Free
Preservative Free
| Provincial Formulary Coverage | ✓:Listed | P:Pending | I:Interchangeable Only |
|---|
| BC | AB | SK | MB | ON | QC | NB | PE | NS | NL |
|---|---|---|---|---|---|---|---|---|---|
| ✓ | ✓ | ✓ | ✓ | N/A | ✓* | N/A | I | I | N/A |
*Partial Benefit
Product Description
Dihydroergotamine (DHE) (dihydroergotamine mesylate injection) is indicated for the treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes, where rapid relief is desired.